XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net revenue $ 30,613 $ 14,237 $ 73,507 $ 36,740
Cost of revenue 17,552 12,463 42,510 28,333
Gross profit 13,061 1,774 30,997 8,407
Operating expenses:        
Research and development 2,501 2,433 6,932 7,608
Sales and marketing 4,515 4,378 12,843 13,036
General and administrative 5,396 5,380 16,054 15,671
Total operating expenses 12,412 12,191 35,829 36,315
Income (loss) from operations 649 (10,417) (4,832) (27,908)
Other expenses (income), net:        
Change in fair value of contingent shares liability   3   (152)
Interest expense 2,861 2,861 8,600 8,549
Other income, net (276) (164) (519) (377)
Total other expenses, net 2,585 2,700 8,081 8,020
Loss before income tax expense (1,936) (13,117) (12,913) (35,928)
Income tax expense 230   684 16
Net loss (2,166) (13,117) (13,597) (35,944)
Other comprehensive loss:        
Unrealized gain resulting from change in fair value of marketable securities 8 26 3 62
Total comprehensive loss $ (2,158) $ (13,091) $ (13,594) $ (35,882)
Loss per common share        
Basic $ (0.03) $ (0.22) $ (0.22) $ (0.6)
Diluted $ (0.03) $ (0.22) $ (0.22) $ (0.6)
Weighted-average common shares outstanding        
Basic 65,683,332 60,608,934 63,226,401 60,130,249
Diluted 65,683,332 60,608,934 63,226,401 60,130,249